OncBioMune Pharmaceuticals, Inc Purchase Agreements

29 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement between Theralink Technologies, Inc. and Purchasers (November 29, 2022)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (April 2022)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (January 2022)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (November 1, 2021)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (Series F Convertible Preferred Stock and Warrants)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (May 12, 2021)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Doug Mergenthaler dated September 16, 2020
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2020
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Investors for Series C-2 Convertible Preferred Stock
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2020
Asset Purchase Agreement between Avant Diagnostics, Inc. and Oncbiomune Pharmaceuticals, Inc. dated May 12, 2020
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2020
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and JEB Partners, L.P. dated September 25, 2019
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Purchasers (June 3, 2019)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Form of Securities Purchase Agreement
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Purchaser (June 26, 2019)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Cavalry Fund I LP, dated March 25, 2019
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and Cerberus Finance Group Ltd
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and LG Capital Funding LLC
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Cavalry Fund I LP dated November 13, 2018
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Purchasers (September 24, 2018)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Securities Purchase Agreement between OncBioMune Pharmaceuticals Inc. and Buyer (July 2018)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Purchasers (March 13, 2018)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Purchasers (January 29, 2018)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Amended and Restated Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Purchasers (November 23, 2016)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2016
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Purchasers (November 18, 2016)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2016
Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (October 20, 2015)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
IL
2015
Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (October 20, 2015)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
IL
2015
Website Asset Purchase Agreement between Lakefield Media Holding AG, Flawsome XLerator GmBH, and PediatRx Inc.
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2013
Asset Purchase Agreement between Apricus Biosciences, Inc. and PediatRx Inc. (Granisol® Assets, Ex-U.S.)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
CA
2012
Asset Purchase Agreement between Cypress Pharmaceuticals, Inc. and PediatRx, Inc. dated July 22, 2010
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2010
Letter of Intent for Acquisition of GRANISOL Assets by Striker Energy Corp. from Cypress Pharmaceutical Inc.
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NJ
2010